What are IlDong Pharmaceutical Co Ltd's marketed drugs?

Top marketed products include Besifovir dipivoxil, V - C - C+V, V - C+V - C.

IlDong Pharmaceutical Co Ltd

3 marketed · 7 in Phase 3

Founded	1941

Besifovir dipivoxil · Virology / Hepatology
Besifovir dipivoxil is a nucleotide reverse transcriptase inhibitor that blocks hepatitis B virus replication by inhibiting the viral reverse transcriptase enzyme.
V - C - C+V · Immunology / Infectious Disease
V-C-C+V is a combination vaccine containing inactivated varicella-zoster virus and other viral components designed to provide immunization against varicella (chickenpox) and related viral infections.
V - C+V - C · Nutritional supplementation
V-C+V-C is a combination product containing vitamins and minerals that provides nutritional supplementation.

Experimental drug
Experimental drug works by targeting a specific molecular pathway to produce a therapeutic effect.
Placebo for Hydrochlorothiazide · Cardiovascular
A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.
Placebo(for Rosuvastatin 10mg)
Placebo does not have a pharmacological effect.
Placebo(for Rosuvastatin 20mg) · Cardiovascular
Placebo is an inert substance with no active pharmacological mechanism.
Placebo for Tamsulosin · Urology
A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.
Placebo(for Telmisartan 80mg) · Cardiovascular
Placebo is an inert substance with no active pharmacological mechanism.
Telmisartan/Amlodipine+Hydrochlorothiazide · Cardiovascular
Telmisartan is an angiotensin II receptor antagonist, while amlodipine is a calcium channel blocker, and hydrochlorothiazide is a thiazide diuretic.

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: